Analytical Data
-
基因名
hDDC
- Application
-
别名
AADC; Aromatic L-Amino Acid Decarboxylase; DOPA decarboxylase
-
种属
Mouse
-
表达系统
E. coli
-
标签
N-His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
O88533
-
表达区间
Lys58~Thr320
-
分子量
32kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
HDDC (Hepatobiliary-specific Dipeptidase-Displaying Chimeric) recombinant protein has emerged as a significant focus of research due to its potential therapeutic applications in liver diseases and metabolic disorders. This protein, characterized by its unique structure and enzymatic function, is produced through recombinant DNA technology, allowing for a greater yield and purity compared to traditional extraction methods. The liver plays a crucial role in various metabolic processes, and any dysfunction can lead to serious health issues, including fatty liver disease, hepatitis, and cirrhosis. By studying HDDC, researchers aim to understand its role in hepatobiliary function and its potential as a biomarker for liver health. Moreover, the reconstruction of protein sequences can lead to novel insights into enzyme activity, enhancing drug design and therapeutic interventions. The ability to manipulate HDDC at the molecular level could also pave the way for innovative treatments for liver-related conditions, providing a basis for developing targeted gene therapies and enzyme replacement therapies. This highlights the importance of HDDC recombinant protein in both basic research and clinical applications, showcasing its potential to significantly impact the field of hepatology and improving patient outcomes.
